华纳药厂：关于完成工商变更登记并换发营业执照的公告

Core Viewpoint - Warner Pharmaceuticals announced significant corporate governance changes, including alterations to registered capital, cancellation of the supervisory board, adjustments to the board of directors, and amendments to the company's articles of association [1] Group 1 - The company will hold its fourth board meeting and fourth supervisory board meeting on December 10, 2025, followed by a second extraordinary shareholders' meeting on December 26, 2025, to review the proposed changes [1] - The company has completed the necessary business registration changes and the filing of the revised articles of association, receiving a new business license from the Changsha Market Supervision Administration [1]